Abstract:The AT‐rich interacting domain‐containing protein 1A (ARID1A) is a tumor suppressor gene that has been implicated in several cancers, including colorectal cancer (CRC). The present study used a proteomic approach to elucidate the molecular mechanisms of ARID1A in CRC carcinogenesis. Stable ARID1A‐overexpressing SW48 colon cancer cells were established using lentivirus transduction and the successful overexpression of ARID1A was confirmed by western blotting. Label‐free quantitative proteomic analysis using liquid chromatography‐tandem mass spectrometry identified 705 differentially altered proteins in the ARID1A‐overexpressing cells, with 310 proteins significantly increased and 395 significantly decreased compared with empty vector control cells. Gene Ontology enrichment analysis highlighted the involvement of the altered proteins mainly in the Wnt signaling pathway. Western blotting supported these findings, as a decreased protein expression of Wnt target genes, including c‐Myc, transcription factor T cell factor‐1/7 and cyclin D1, were observed in ARID1A‐overexpressing cells. Among the altered proteins involved in the Wnt signaling pathway, the interaction network analysis revealed that ARID1A exhibited a direct interaction with E3 ubiquitin‐protein ligase zinc and ring finger 3 (ZNRF3), a negative regulator of the Wnt signaling pathway. Further analyses using the The Cancer Genome Atlas colon adenocarcinoma public dataset revealed that ZNRF3 expression significantly impacted the overall survival of patients with CRC and was positively correlated with ARID1A expression. Finally, an increased level of ZNRF3 in ARID1A‐overexpressing cells was confirmed by western blotting. In conclusion, the findings of the present study suggest that ARID1A negatively regulates the Wnt signaling pathway through ZNRF3, which may contribute to CRC carcinogenesis.

ARID1A regulates R-loop associated DNA replication stress

ARID1A regulates DNA repair through chromatin organization and its deficiency triggers DNA damage-mediated anti-tumor immune response

ARID1A Deficiency Impairs the DNA Damage Checkpoint and Sensitizes Cells to PARP Inhibitors.

ADAR1 links R-loop homeostasis to ATR activation in replication stress response

Tumor suppressor role of chromatin-remodeling factor ARID1A]

Increased genomic instability and reshaping of tissue microenvironment underlie oncogenic properties of Arid1a mutations

ARID1A Deficiency Weakens BRG1-RAD21 Interaction That Jeopardizes Chromatin Compactness and Drives Liver Cancer Cell Metastasis.

ZFP161 regulates replication fork stability and maintenance of genomic stability by recruiting the ATR/ATRIP complex

Research Progress of the Tumor Suppressor ARID1A

ARID1A suppresses R-loop-mediated STING-type I interferon pathway activation of anti-tumor immunity

Chromatin Remodeling Factor CHR18 Interacts with Replication Protein RPA1A to Regulate the DNA Replication Stress Response in Arabidopsis

NKAP Acts with HDAC3 to Prevent R-loop Associated Genome Instability

The post translational modification of key regulators of ATR signaling in DNA replication

Treating ARID1A mutated cancers by harnessing synthetic lethality and DNA damage response

APOBEC3B Coordinates R-loop to Promote Replication Stress and Sensitize Cancer Cells to ATR/Chk1 Inhibitors

Loss of ARID1A in Tumor Cells Renders Selective Vulnerability to Combined Ionizing Radiation and PARP Inhibitor Therapy

Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma

Topoisomerase 1 prevents replication stress at R-loop-enriched transcription termination sites

Advances in research on ARID1 A in Malignancies

Deciphering the regulatory mechanisms and biological implications of ARID1A missense mutations in cancer

Proteomic insights into the regulatory function of ARID1A in colon cancer cells